Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation. (Q54362486)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Xiao-Su Zhao

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Yan-Rong Liu

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Hong-Hu Zhu

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Lan-Ping Xu

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Dai-Hong Liu

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kai-Yan Liu

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

28 June 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Annals of Hematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

91

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

183-192

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Residual leukaemia after bone marrow transplant in children with acute lymphoblastic leukaemia after first haematological relapse or with poor initial presenting features.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Minimal residual disease studies by flow cytometry in acute leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Flow Cytometric Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC).

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1285-1

21 January 2018

Identifiers

10.1007/S00277-011-1285-1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710165%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54362486&oldid=1767157603"